OCT 07, 2019 11:51 AM PDT

Evolutionary-Busting Cancer Drug

WRITTEN BY: Nouran Amin

Researchers at the Institute of Cancer Research in London have discovered that a new type of drug that blocks treatment in cancers. The drug works by inhibiting a cancer's key evolutionary escape route from chemotherapy which can be used to treat aggressive breast cancer. Known as BOS172722, the drug forces cancer cells to multiply quickly by blocking the activity of a molecule called MPS1.

Learn more about treatment-resistant cancers and previous studies regarding developing therapeutics to combat such a challenge:

"We have discovered a brand new type of cancer treatment that uses cancer's rapid growth against it, by forcing cells through cell division so quickly that they accumulate fatal errors. The drug works especially well in combination with chemotherapy in triple negative breast cancer cells -- the deadliest form of breast cancer for which there are few successful treatments,” says Professor Spiros Linardopoulos, Professor of Cancer Biology and Therapeutics at The Institute of Cancer Research, London.

"Crucially, the combination is anticipated to be effective in cancer patients that have already become resistant to chemotherapy alone and has the potential to become a much-needed extra treatment option that could extend the lives of patients. The phase I trial of this combination is currently well under way and I look forward to the results."

The evolution-busting therapeutic will begin its first clinical trial on solid tumors such as aggressive triple-negative breast cancers and may also be effective against ovarian cancer. Findings of the study published in the journal Molecular Cancer Therapeutics explains the sensitivity of some cancers upon blocking MPS1 even at low doses.

"Cancer's ability to evolve and become drug resistant is the cause of the vast majority of deaths from the disease. We plan to counter that ability with the world's first 'Darwinian' drug discovery programme within our Centre for Cancer Drug Discovery, dedicated to creating a new generation of anti-evolution treatments,” says Professor Rajesh Chopra, Director of Cancer Therapeutics in the new Centre for Cancer Drug Discovery.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 27, 2019
Drug Discovery & Development
NOV 27, 2019
New Painkiller More Effective than Opioids Discovered in Mud
Researchers have discovered a new painkiller dubbed to be as effective as opioids, only minus their disadvantages, from a 16-year old mud sample found near...
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
Vaccine To Protect Against The Zika Virus
Scientists at The University of Texas Medical Branch at Galveston present for the first time how a single high dose vaccine can protect a pregnant mouse al...
DEC 20, 2019
Drug Discovery & Development
DEC 20, 2019
Drug Repurposing May Provide Hope for Deadly Childhood Seizure Disorder
The life-threatening and treatment-resistant seizure disorder among children known as the ‘Dravet Syndrome’ may soon have new safe and effectiv...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
FDA Approves Drugs Faster than Ever- But is That Good?
The Food and Drug Administration (FDA) is approving new drugs for patients on less and less evidence thanks to special programs that streamline their appro...
JAN 21, 2020
Cannabis Sciences
JAN 21, 2020
Medical Marijuana Ineffective for Long Term Pain Management
Medicinal cannabis may not as effective as once thought as a solution for sleep problems for those with chronic pain in the long run, according to new find...
FEB 21, 2020
Health & Medicine
FEB 21, 2020
Should You Really be Scared of the Coronavirus?
As of February 21st, the death toll for coronavirus reached 2,250, 55,707 currently infected, of which 12,066 (22%) are in a serious or critical condition....
Loading Comments...